Christoph Schaab
YOU?
Author Swipe
View article: Supplementary Figure 2 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Figure 2 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
PDF file - 269K, Effect of RG7356 on p-MEK1/2 signal in MDA-MB 231 xenografts
View article: Supplementary Table 1 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Table 1 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
XLS file - 3.5M, Phosphoproteomics Raw Data
View article: Supplementary Figure 4 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Figure 4 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
PDF file - 105K, Background optimization of p-ERK1/2-ELISA by use of alternative blocking buffers
View article: Supplementary Figure 4 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Figure 4 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
PDF file - 105K, Background optimization of p-ERK1/2-ELISA by use of alternative blocking buffers
View article: Data from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Data from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
The cell surface glycoprotein CD44 plays an important role in the development and progression of various tumor types. RG7356 is a humanized antibody targeting the constant region of CD44 that shows antitumor efficacy in mice implanted with…
View article: Supplementary Table 1 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Table 1 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
XLS file - 3.5M, Phosphoproteomics Raw Data
View article: Supplementary Figure 1 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Figure 1 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
PDF file - 490K, Overview of regulated phosphoprotein networks after 4.5h anti-CD44 treatment compared to the vehicle control
View article: Data from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Data from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
The cell surface glycoprotein CD44 plays an important role in the development and progression of various tumor types. RG7356 is a humanized antibody targeting the constant region of CD44 that shows antitumor efficacy in mice implanted with…
View article: Supplementary Figure 1 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Figure 1 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
PDF file - 490K, Overview of regulated phosphoprotein networks after 4.5h anti-CD44 treatment compared to the vehicle control
View article: Supplementary Figure 3 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Figure 3 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
PDF file - 336K, No modulation of signaling in PL45 xenografts after RG7356 treatment
View article: Supplementary Figure 3 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Figure 3 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
PDF file - 336K, No modulation of signaling in PL45 xenografts after RG7356 treatment
View article: Supplementary Figure 2 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Supplementary Figure 2 from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist Open
PDF file - 269K, Effect of RG7356 on p-MEK1/2 signal in MDA-MB 231 xenografts
View article: Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial
Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial Open
Human protein biomarker discovery relies heavily on pre-clinical models, in particular established cell lines and patient-derived xenografts, but confirmation studies in primary tissue are essential to demonstrate clinical relevance. We de…
View article: Compartment-resolved Proteomic Analysis of Mouse Aorta during Atherosclerotic Plaque Formation Reveals Osteoclast-specific Protein Expression
Compartment-resolved Proteomic Analysis of Mouse Aorta during Atherosclerotic Plaque Formation Reveals Osteoclast-specific Protein Expression Open
View article: Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells
Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells Open
View article: Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models
Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models Open
View article: Integrated genomics and proteomics define huntingtin CAG length–dependent networks in mice
Integrated genomics and proteomics define huntingtin CAG length–dependent networks in mice Open
View article: Time‐ and compartment‐resolved proteome profiling of the extracellular niche in lung injury and repair
Time‐ and compartment‐resolved proteome profiling of the extracellular niche in lung injury and repair Open
View article: Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib
Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib Open
Multivariate biomarkers that can predict the effectiveness of targeted therapy in individual patients are highly desired. Previous biomarker discovery studies have largely focused on the identification of single biomarker signatures, aimed…